HPSE2 and glomerulonephritis: To further explore the therapeutic potential of HPSE2, the HPSE2 protein and a mix of the HPSE2 peptides 381–410, 391–420, and 401–430 were tested as inhibitors in the LPS-induced glomerulonephritis mouse model.